Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
sargramostim gmcsfr-alpha NA Successful target TTD , DGIDB Malignant Neoplasms[MeSHID:D009369]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
47.74 approved unknown
sargramostim granulocyte-macrophage colony-stimulating factor receptor subunit alpha biotech NA drugbank , DGIDB Malignant Neoplasms[MeSHID:D009369]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
47.74 approved,investigational agonist
sargramostim gmcsfr-alpha NA Successful target TTD , DGIDB Malignant Neoplasms[MeSHID:D009369]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
47.74 approved agonist
sargramostim cytokine receptor common subunit beta biotech NA drugbank , DGIDB Malignant Neoplasms[MeSHID:D009369]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
47.74 approved,investigational agonist
sargramostim interleukin-3 receptor subunit alpha biotech NA drugbank Malignant Neoplasms[MeSHID:D009369]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA approved,investigational agonist
sargramostim bone marrow proteoglycan biotech NA drugbank Malignant Neoplasms[MeSHID:D009369]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA approved,investigational unknown
sargramostim syndecan-2 biotech NA drugbank Malignant Neoplasms[MeSHID:D009369]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA approved,investigational agonist
click here to return to the previous page